Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Fluoxetine trial in borderline personality disorder.

Cornelius JR, Soloff PH, Perel JM, Ulrich RF.

Psychopharmacol Bull. 1990;26(1):151-4.

PMID:
2371370
2.

A preliminary trial of fluoxetine in refractory borderline patients.

Cornelius JR, Soloff PH, Perel JM, Ulrich RF.

J Clin Psychopharmacol. 1991 Apr;11(2):116-20.

PMID:
2056138
3.

Fluoxetine in borderline personality disorder.

Norden MJ.

Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(6):885-93.

PMID:
2813806
4.

[Borderline personality disorder, self-mutilation and suicide: literature review].

Oumaya M, Friedman S, Pham A, Abou Abdallah T, Guelfi JD, Rouillon F.

Encephale. 2008 Oct;34(5):452-8. doi: 10.1016/j.encep.2007.10.007. Epub 2008 Feb 20. Review. French.

PMID:
19068333
5.

Borderline personality disorder in major depression: symptomatology, temperament, character, differential drug response, and 6-month outcome.

Joyce PR, Mulder RT, Luty SE, McKenzie JM, Sullivan PF, Cloninger RC.

Compr Psychiatry. 2003 Jan-Feb;44(1):35-43.

PMID:
12524634
6.
7.

[Fluoxetine in the treatment of borderline personality disorder].

Silva H, Jerez S, Paredes A, Salvo J, Rentería P, Ramírez A, Montes C.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1997 Nov-Dec;25(6):391-5. Spanish.

PMID:
9477607
8.

Venlafaxine in the treatment of borderline personality disorder.

Markovitz PJ, Wagner SC.

Psychopharmacol Bull. 1995;31(4):773-7.

PMID:
8851652
9.

An open-label trial of divalproex extended-release in the treatment of borderline personality disorder.

Simeon D, Baker B, Chaplin W, Braun A, Hollander E.

CNS Spectr. 2007 Jun;12(6):439-43.

PMID:
17545954
10.

Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder.

Silva H, Iturra P, Solari A, Villarroel J, Jerez S, Vielma W, Montes C, Pumarino L, Roa N.

Actas Esp Psiquiatr. 2007 Nov-Dec;35(6):387-92.

PMID:
17597424
11.

Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.

Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, Schwartz J, Miyawaki E.

J Clin Psychopharmacol. 1995 Feb;15(1):23-9.

PMID:
7714224
12.

Impulsive aggression in borderline personality disorder.

Goodman M, New A.

Curr Psychiatry Rep. 2000 Feb;2(1):56-61. Review.

PMID:
11122933
13.

Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.

Van den Eynde F, Senturk V, Naudts K, Vogels C, Bernagie K, Thas O, van Heeringen C, Audenaert K.

J Clin Psychopharmacol. 2008 Apr;28(2):147-55. doi: 10.1097/JCP.0b013e318166c4bf.

PMID:
18344724
14.

Treatment of borderline personality disorder with risperidone.

Rocca P, Marchiaro L, Cocuzza E, Bogetto F.

J Clin Psychiatry. 2002 Mar;63(3):241-4.

PMID:
11926724
15.

Efficacy of phenelzine and haloperidol in borderline personality disorder.

Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.

Arch Gen Psychiatry. 1993 May;50(5):377-85.

PMID:
8489326
16.

Time series analysis of intervention effects. Fluoxetine therapy as a case illustration.

Hull JW, Clarkin JF, Alexopoulos GS.

J Nerv Ment Dis. 1993 Jan;181(1):48-53.

PMID:
8419515
17.

Yi-gan san for the treatment of borderline personality disorder: an open-label study.

Miyaoka T, Furuya M, Yasuda H, Hayashia M, Inagaki T, Horiguchi J.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):150-4. Epub 2007 Aug 8.

PMID:
17765378
18.

Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Bellino S, Paradiso E, Bogetto F.

CNS Drugs. 2008;22(8):671-92. Review.

PMID:
18601305
19.

[Symptom-focussed drug therapy in borderline personality disorder].

Schmahl C, Bohus M.

Fortschr Neurol Psychiatr. 2001 Jul;69(7):310-21. Review. German.

PMID:
11488246
20.

Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder.

Benedetti F, Sforzini L, Colombo C, Maffei C, Smeraldi E.

J Clin Psychiatry. 1998 Mar;59(3):103-7.

PMID:
9541151

Supplemental Content

Support Center